Rush Cancer Institute at Rush University Medical Center — Chicago, Illinois

Rush Cancer Institute at Rush University Medical Center is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Rush Cancer Institute at Rush University Medical Center has participated in 11 clinical trials.

Therapeutic areas: Lymphoma, Leukemia, Lung Cancer.

Sponsors: Genitope Corporation, The Vaccine Company, Northwestern University.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush Cancer Institute at Rush University Medical Center?

Rush Cancer Institute at Rush University Medical Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush Cancer Institute at Rush University Medical Center conducted?

Rush Cancer Institute at Rush University Medical Center has 11 clinical trials on record. Their work covers Lymphoma, Leukemia, Lung Cancer.

Is Rush Cancer Institute at Rush University Medical Center accredited by Crixeo Health?

Yes — Rush Cancer Institute at Rush University Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rush Cancer Institute at Rush University Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.